Breast Cancer Clinical Trials in Los Angeles

Showing 441-460 of 492 trials

A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue

NCT00727662

This randomized controlled trial will compare the effectiveness of an Iyengar Yoga intervention to a Wellness Seminar health education lecture series, for improvements in energy, mood and biological functioning in breast cancer survivors with persistent, post-treatment fatigue. It is anticipated that the Iyengar Yoga intervention will be feasible and acceptable to breast cancer survivors with minimal side effects and that the Yoga intervention will be effective in improving fatigue and physical performance.

Breast CancerFatigue

National Center for Complementary and Integrative Health (NCCIH)72 participantsStarted Jun 2008

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

NCT00320710

Clinical trial in breast cancer patients with bone metastases pretreated for approximately 1 year with a standard zoledronic acid regimen. Looking at the continued effectiveness and safety of giving zoledronic acid every 4 weeks versus every 12 weeks given over 1 year. This study is prospective, double-blind, stratified, multi-center, and two-arm.

Breast Cancer

Novartis Pharmaceuticals416 participantsStarted Feb 2006

Anchorage, Alaska, United States • Hot Springs, Arkansas, United States • Springdale, Arkansas, United States +89 more locations

A Yoga and Wellness Program for Breast Cancer Survivors With Persistent Fatigue

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Breast Cancer Trials in Other Cities

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer

IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

Other Conditions in Los Angeles